Mometasone Furoate Sandoz Ltd (Mometasone Furoate)

Mometasone furoate is a potent glucocorticoid that binds to intracellular glucocorticoid receptors in nasal mucosal cells. This binding modifies gene transcription, leading to reduced production of inflammatory cytokines, chemokines, and adhesion molecules, which in turn diminishes inflammatory cell infiltration and edema in the nasal lining.

The specific dosing regimen for Mometasone Furoate nasal spray is determined by the prescribing healthcare professional based on the patient’s age, severity of symptoms, and clinical response. Typically, the label recommends one spray per nostril once daily, but the exact dose and frequency should follow the prescriber’s instructions.

Safety data for mometasone furoate in pregnancy and lactation are limited. Women who are pregnant, planning to become pregnant, or breastfeeding should discuss potential risks and benefits with their healthcare provider before using the product.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India supplies hospitals, pharmacies and procurement teams worldwide. After submission, the sales team will verify trade or institutional credentials, then provide pricing, availability, shipping details (including any cold‑chain requirements), and assist with import documentation.

Both mometasone furoate and fluticasone are intranasal corticosteroids with similar anti‑inflammatory mechanisms. Mometasone is often noted for its high receptor affinity and once‑daily dosing, while fluticasone may have a slightly different safety profile regarding systemic absorption. Clinical choice depends on physician preference, patient response, and formulary considerations.

Store the nasal spray at room temperature, away from direct sunlight and moisture. Keep the product in its original packaging until use, and ensure the cap is tightly closed after each application to maintain sterility and potency.

Before first use, prime the spray by actuating it a few times until a fine mist appears. Gently blow the nose, tilt the head slightly forward, insert the tip into one nostril, close the opposite nostril with a finger, and press the pump while breathing in gently through the nose. Repeat in the other nostril if prescribed.

Serious adverse events, though rare, include nasal septal perforation, severe allergic reactions such as anaphylaxis, adrenal suppression leading to systemic glucocorticoid effects, and ocular complications like increased intra‑ocular pressure or cataract formation. Patients should seek immediate medical attention if they experience any of these symptoms.

The spray should be avoided in individuals with known hypersensitivity to mometasone furoate or any component of the formulation. It is also contraindicated in patients with active untreated fungal, bacterial, or viral infections of the nasal passages, and in those who have recently undergone nasal surgery until healing is complete.